Published on 29 Nov 2022 on Zacks · via Yahoo Finance
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Lags Revenue Estimates
MaxCyte, Inc. (MXCT) delivered earnings and revenue surprises of 0% and 1.99%, respectively, for the...
NASDAQ.THMO price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free